Healthcare products
Child Health
Deficiency States and Supplementation
Dermatological Health
Pain treatment
Gastrointestinal Health
Genitourinary Health
Cardiorespiratory Health
Corticotherapy
Oral-Pharyngeal Health
Fluid Therapy
CNS Treatment
News
Incremental Drug Innovation: A Priority Focus for Laboratorios ERN
David Solanes López, General Manager of Laboratorios ERN, was appointed Academician of the Royal Academy of Pharmacy of Catalonia on October 6, 2025, in the industrial section Solanes dedicated his induction speech to incremental innovation, an area closely linked to his professional career and to Laboratorios ERN’s commitment to developing solutions...
FDA has approved intravenous fosfomycin for the treatment of cUTI
On October 22, 2025, the US Food and Drug Administration (FDA) approved intravenous fosfomycin for the treatment of complicated urinary tract infections (cUTI) Laboratorios ERN expresses its satisfaction with the recent approval by the US Food and Drug Administration (FDA) of intravenous fosfomycin for the treatment of patients aged 18 years and older...
Laboratorios ERN collaborates with the Master’s in Logistics and Supply Chain Management at the University of Barcelona
The collaboration with the Institut de Formació Contínua–IL3 allows students to apply their knowledge to a real case in the pharmaceutical sector Laboratorios ERN has strengthened its ties with the academic field through a collaboration with the Master’s in Logistics and Supply Chain Management at the Institut de Formació Contínua–IL3, part of...
“Una rosa per no oblidar”
Once again, on the occasion of Sant Jordi's Day, April 23rd, 2025, Laboratorios ERN has renewed its commitment to solidarity by joining the Fundació Alzheimer Catalunya As we did in 2024, we wanted to convey a message of support to all people affected by Alzheimer's disease Each rose delivered represents much more than a flower: it is a living symbol of...
Laboratorios ERN’s Presence at the Meeting with the President of the Spanish Government
David Solanes López, General Director of Laboratorios ERN, met on February 12, 2025, with the President of the Government of Spain, Pedro Sánchez, along with other executives from the national and multinational pharmaceutical industry, Farmaindustria, EFPIA, and the Minister of Health, Mónica García, the Minister of Industry, Jordi Hereu, and other...
ERN applies for the MOVES III grant
LABORATORIOS ERN has applied for the MOVES III program grant for the installation of electric vehicle charging points at its Barcelona headquarters and its center in Sant Andreu de la Barca The charging points, already operational, reflect its commitment to sustainability and the promotion of electric mobility as a key pillar of its environmental...